Clinical Trial Update: BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study evaluating BN104 in combination with chemotherapy or targeted agents for Acute Myeloid Leukemia, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BN104

Snippet

Sponsor: Chen Suning | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING